Replies to post #35534 on DNAprint Genomics (DNAG)

[dr frudaky]

Gcbr


Logistical procedural efficiency in analysis for DNAG's specialized protocol cannot overcome the fact that the general forensics market is not generating significant revenues for certified companies, such as ORCH, which is head and shoulders above DNAG in this field of technology. Check out the recent news reports regarding ORCH's problems.

So you are saying Frudakis was trying to "keep people off the trail" of his valuable revenue generating forensics technology, even though all his patent applications have been fully published for all the public to see? Please try again! LOL!

JMHO from the facts.

dr f